Inventor · disambiguated record
Philip C. Lang
Also filed as: LANG PHILIP C
9 granted patents·7 pending applications·250 citations·filing 1980–2008
90Inventor score
Files withROBERTS LAB INC3SHIRE US INC3DEXGEN PHARMACEUTICALS INC2DRUMMOND GEORGE S2TOMS RIVER CHEMICAL CORP1
Top patents by PatentIndex Score
16 records- 0193US6541043B2Method and synergistic composition for treating attention deficit/hyperactivity disorderDEXGEN PHARMACEUTICALS INC·Filed 2001·Granted Apr 1, 2003·79 cites·20 claims
- 0289US6583152B2Composition for reducing the risk or progression of cardiovascular diseasesDEXGEN PHARMACEUTICALS INC·Filed 2001·Granted Jun 24, 2003·40 cites·5 claims
- 0385US6388073B1Method for the manufacture of anagrelideSHIRE US INC·Filed 2000·Granted May 14, 2002·20 cites·2 claims
- 0485US5801245AProcess for the preparation of ethyl-N-(2,3 dichloro-6-nitrobenzyl) glycineROBERTS LAB INC·Filed 1997·Granted Sep 1, 1998·36 cites·4 claims
- 0580US6653500B2Method for the manufacture of AnagrelideSHIRE US INC·Filed 2002·Granted Nov 25, 2003·13 cites·6 claims
- 0677US6194420B12-amino-5,6-dichloro-3,4-dihydroquinazoline, its method of making and using and pharmaceutical compositions thereofROBERTS LAB INC·Filed 1999·Granted Feb 27, 2001·22 cites·15 claims
- 0774US5962488AStable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivativesROBERTS LAB INC·Filed 1998·Granted Oct 5, 1999·33 cites·17 claims
- 0868US2008261939A1Stannsoporfin compositions and administrationDRUMMOND GEORGE S·Filed 2008·Application pending·0 cites
- 0960US2006222669A1Stannsoporfin compositions and administrationDRUMMOND GEORGE S·Filed 2005·Application pending·0 cites
- 1058US2006222668A1Stannsoporfin compositions, drug products and methods of manufactureWELLSPRING PHARMACEUTICAL CORP·Filed 2005·Application pending·0 cites
- 1157US2003220225A1Composition and method for reducing the risk or progression of cardiovascular, glaucoma and tardive dyskinesia diseasesFiled 2003·Application pending·0 cites
- 1257US2004082500A1Composition and method for reducing the risk or progression of cardiovascular, glaucoma and tardive dyskinesia diseasesFiled 2003·Application pending·0 cites
- 1356US4283556AProcess for the manufacture of substantially pure 3-amino-4-alkoxy-acylanilides from 2,4-dinitrochlorobenzeneTOMS RIVER CHEMICAL CORP·Filed 1980·Granted Aug 11, 1981·5 cites·12 claims
- 1448US2004087479A1Composition and method for reducing the risk or progression of cardiovascular, glaucoma, tardive dyskinesia and other diseasesFiled 2003·Application pending·0 cites
- 1536US6479529B1Antioxidant stabilizer system for pharmaceutical formulationsSHIRE US INC·Filed 1999·Granted Nov 12, 2002·2 cites·8 claims
- 1636US2003114673A12-amino-5,6-dihalo-3,4-dihydroquinazolines with blood platelet reducing propertiesFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philip C. Lang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →